Cargando…
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
BACKGROUND: Tofacitinib is a disease-modifying antirheumatic drug (DMARD) which was recently approved by US Food and Drug Administration (FDA). There are several randomised clinical trials (RCTs) that have investigated the efficacy and safety of tofacitinib in adult patients with rheumatoid arthriti...
Autores principales: | He, Ying, Wong, Angel YS, Chan, Esther W, Lau, Wallis CY, Man, Kenneth KC, Chui, Celine SL, Worsley, Alan J, Wong, Ian CK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819708/ https://www.ncbi.nlm.nih.gov/pubmed/24139404 http://dx.doi.org/10.1186/1471-2474-14-298 |
Ejemplares similares
-
Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries
por: Ju, Chengsheng, et al.
Publicado: (2021) -
Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis
por: Li, Zhan-Guo, et al.
Publicado: (2018) -
Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
por: Mariette, Xavier, et al.
Publicado: (2018) -
Medication safety research by observational study design
por: Lao, Kim S. J., et al.
Publicado: (2016) -
Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
por: Clowse, Megan E. B., et al.
Publicado: (2016)